MASS
Q4 2026 EPS Estimate
$-0.16
Nov 9, 2026 · Reports before open
Revenue Estimate
$19M

Analyst Sentiment

Wall St. Consensus
Buy
6 analysts·Limited coverage
75
Score
6 Buy (100%)0 Hold (0%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
6100%
Hold
00%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$12.00
+12.4%
Consensus
$12.00
+12.4%
Bull
$12.00
+12.4%
12-Month Target Range6 analysts
$12.00$12.00$12.00
Current $10.68Consensus
Current Price
$10.68
Upside to Consensus
$1.32

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+19.42%
EPS
FY2028
Rev+18.02%
EPS
FY2029
Rev+4.37%
EPS
Raw consensus estimates (low / average / high) from covering analysts.
Annual
MetricFY2026EFY2027EFY2028EFY2029E
Revenue Avg$69M$83M$98M$102M
Low$69M$82M$93M$100M
High$70M$84M$102M$104M
EBITDA Avg$-45M$-53M$-63M$-66M
Low$-45M$-54M$-66M$-67M
High$-45M$-53M$-60M$-65M
EBIT Avg$-48M$-58M$-68M$-71M
Low$-49M$-58M$-71M$-72M
High$-48M$-57M$-65M$-70M
Net Income Avg$-30M$-14M$-9M$-8M
Low$-34M$-16M$-10M$-8M
High$-26M$-13M$-9M$-8M
EPS Avg$-0.77$-0.37$-0.23$-0.20
Low$-0.88$-0.41$-0.25$-0.20
High$-0.66$-0.33$-0.22$-0.20
Analysts (Rev / EPS)4 / 24 / 32 / 21 / 1
Quarterly
MetricQ3 2026Q4 2026Q1 2027Q2 2027Q3 2027Q4 2027
Revenue Avg$19M$21M$17M$19M$22M$25M
Low$18M$21M$17M$19M$21M$24M
High$19M$22M$18M$20M$23M$26M
EBITDA Avg$-12M$-14M$-11M$-12M$-14M$-16M
Low$-12M$-14M$-12M$-13M$-15M$-16M
High$-12M$-13M$-11M$-12M$-14M$-15M
EBIT Avg$-13M$-15M$-12M$-13M$-15M$-17M
Low$-13M$-15M$-12M$-14M$-16M$-18M
High$-13M$-14M$-12M$-13M$-15M$-17M
Net Income Avg$-4M$-3M$-5M$-4M$-3M$-2M
Low$-5M$-3M$-5M$-4M$-4M$-2M
High$-3M$-2M$-4M$-4M$-3M$-2M
EPS Avg$-0.12$-0.07$-0.12$-0.10$-0.09$-0.06
Low$-0.14$-0.08$-0.13$-0.11$-0.09$-0.06
High$-0.09$-0.06$-0.12$-0.10$-0.09$-0.05
Analysts (Rev / EPS)4 / 24 / 22 / 12 / 12 / 12 / 1

Earnings Surprises

Recent Analyst Actions

Aug 12, 2026Stifel Nicolaus
908 Devices Inc. (MASS) PT Raised to $12 at Stifel on Q2 Beat and Upward Tweak to Guide
Target:$12.00
+24.9%from $9.61
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.